FIELD: medicine.
SUBSTANCE: invention relates to medicine. Described is implant, which can be injected in subcutaneous or intracutaneous way in form of monophase hydrogel, which contains gel, obtained from cross-linked hyaluronic acid and one of its physiologically acceptable salts.
EFFECT: obtaining subcutaneous implant used for filling wrinkles and stimulation of epidermal cells and/or supporting mechanical properties of skin density and elasticity.
15 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVEMENTS IN ORGANIC COMPOUNDS OR IMPROVEMENTS RELATED TO ORGANIC COMPOUNDS | 2018 |
|
RU2788453C2 |
| COMBINATION OF HYALURONIC ACID AND SULPHATED POLYSACCHARIDE | 2015 |
|
RU2683567C2 |
| DERMAL FILLER COMPOSITION FOR SMALL WRINKLES TREATING | 2012 |
|
RU2626513C2 |
| COMPOSITION OF SKIN FILLER AND TREATMENT METHOD | 2012 |
|
RU2679317C1 |
| SKIN FILLERS COMPOSITIONS | 2012 |
|
RU2638713C2 |
| COMPOSITION COMPRISING HYALURONIC ACID AND MEPIVACAINE | 2014 |
|
RU2670617C2 |
| METHOD OF ANTI-AGING THERAPY | 2016 |
|
RU2610010C1 |
| INJECTED MEDICAL COMPOSITION | 2021 |
|
RU2788726C1 |
| DERMAL INJECTABLE STERILE COMPOSITION | 2013 |
|
RU2653729C2 |
| COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF SKIN | 2016 |
|
RU2718873C2 |
